Skip to content

Acadia Pharmaceuticals ACAD Market capitalization

Market capitalization at other companies

Biogen logo
BiogenBIIB
$26.91B+34.3%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$13.22B+19.9%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$3.02B+2.7%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$5.64B+40.3%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$14.4B+119%
TG Therapeutics logo
TG TherapeuticsTGTX
$5.3B-14.3%

Other financials

Income statement

See full
Revenue$268.1M+9.7%
Gross profit$243.3M+8.6%
Operating income-$4.6M-124%
Net income$3.6M-80.8%
EPS (diluted)$0.02-81.8%

Balance sheet

See full
Cash & equivalents$282.2M+29.6%
Total debt$50.8M-9.3%
Total equity$1.2B+63.1%
Total assets$1.6B+41.8%

Cash flow

See full
Operating cash flow$34.0M+67.2%
CapEx$5.2M
Free cash flow$28.8M+41.6%

Valuation

See full
Enterprise value$3.47B+36.6%
P/E9.9×-2.0×
P/S3.4×+0.7×

Profitability

See full
Gross margin91.5%-0.6pp
Operating margin7.4%-16.2pp
Net margin34.3%+11.3pp
FCF margin18.9%

Returns & leverage

See full
Return on equity37.3%+0.1pp
Debt / equity0.0×
Current ratio3.6×+0.7×

Where this comes from

Computed from the period-end share price: $3.8B.

The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Acadia Pharmaceuticals's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Acadia Pharmaceuticals's market capitalization?
Acadia Pharmaceuticals (ACAD) reported market capitalization of $3.8B in Q1 2026.
How has Acadia Pharmaceuticals's market capitalization changed year-over-year?
Acadia Pharmaceuticals's market capitalization increased by 37.0% year-over-year, from $2.77B to $3.8B.
What is the long-term trend for Acadia Pharmaceuticals's market capitalization?
Over 5 years (2020 to 2025), Acadia Pharmaceuticals's market capitalization has grown at a -12.1% compound annual growth rate (CAGR), from $8.59B to $4.52B.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.